Kang, Mi Hyun <br/><br/>
Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells.  [electronic resource] 

 -  Cancer research and treatment  Jan 2016 
 - 355-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2005-9256 
<br/><br/><label>Standard No.: </label>10.4143/crt.2014.260  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Camptothecin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Colorectal Neoplasms--drug therapy<br/>Drug Synergism<br/>ErbB Receptors--antagonists & inhibitors<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Fluorouracil--pharmacology<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>Irinotecan<br/>Organoplatinum Compounds--pharmacology<br/>Oxaliplatin<br/>Protein Biosynthesis--drug effects<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Quinazolines--administration & dosage